Comparison of short bowel syndrome acquired early in life and during adolescence

Matias Bruzoni1, Debra L Sudan, Robert A Cusick

  • 1Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA. mbruzoni@unmc.edu

Transplantation
|July 16, 2008
PubMed

Insights

Adults who developed short bowel syndrome (SBS) in childhood have similar long-term outcomes to those who developed SBS in adolescence. Despite differing causes and anatomy, both groups require similar treatments like parenteral nutrition and intestinal transplant.

Area of Science:

  • Gastroenterology
  • Pediatric Surgery
  • Transplant Surgery

Background:

  • Short bowel syndrome (SBS) survival has improved with parenteral nutrition and intestinal transplantation.
  • Hypothesized differences exist between adult SBS patients who developed the condition in childhood versus adolescence.

Purpose of the Study:

  • To investigate potential differences in etiology, intestinal anatomy, and long-term outcomes between adult patients with SBS originating in childhood versus adolescence.

Main Methods:

  • Studied 67 patients aged 16–40 years.
  • Divided into a pediatric group (PG; n=30, SBS onset <12 years) and an adolescent group (AG; n=37, SBS onset 13–25 years).

Main Results:

  • Pediatric group (PG) causes: midgut volvulus, gastroschisis, intestinal atresia. Adolescent group (AG) causes: trauma, tumors, postoperative complications.
  • PG had more colon remnants (97% vs. 71%) and fewer ostomies (7% vs. 47%) than AG.
  • Both groups had similar rates of short intestinal remnants (<60 cm), need for parenteral nutrition, and intestinal transplant; PG had worse height z-scores.

Conclusions:

  • Pediatric patients developing SBS early in life show similar long-term outcomes to adolescent-onset SBS patients.
  • Differences in SBS origin and intestinal anatomy do not appear to significantly alter long-term outcomes.
  • Acknowledges inherent biases in group definitions.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...